Brief: Quince Therapeutics Settles EIB Loan Obligations For $5.5 Mln
30/03/2026 17:32
March 30 (Reuters) - Quince Therapeutics Inc QNCX.O: QUINCE THERAPEUTICS - SETTLES EIB LOAN OBLIGATIONS FOR $5.5 MILLION - SEC FILING Source text: [ID:n0001193125-26-130489] Further company coverage: QNCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges